BACKGROUND: We assessed morbidity rates during short intervals that accompanied weaning and cumulative mortality among HIV-exposed, uninfected infants enrolled in the postexposure prophylaxis of infants in Malawi (PEPI-Malawi) trial. METHODS: Women were counseled to stop breastfeeding (BF) by 6 months in the PEPI-Malawi trial. HIV-uninfected infants were included in this analysis starting at age 6 months. Breastfeeding and morbidity (illness and/or hospital admission and malnutrition [weight-for-age Z-score, ≤2]) were assessed during age intervals of 6-9, 9-12, and 12-15 months. BF was defined as any BF at the start and end of the interval and no breastfeeding (NBF) was defined as NBF at any time during the interval. The association of NBF with morbidity at each mutually exclusive interval was assessed using Poisson regression models controlling for other factors. Cumulative mortality among infants aged 6-15 months with BF and NBF was assessed using an extended Kaplan-Meier method. RESULTS: At age 6 months, 1761 HIV-uninfected infants were included in the study. The adjusted rate ratios for illnesses and/or hospital admission for NBF, compared with BF, was 1.7 (P < .0001) at 6-9 months, 1.66 (P = .0001) at 9-12 months, and 1.75 (P = .0008) at 12-15 months. The rates of morbidity were consistently higher among NBF infants during each age interval, compared with BF infants. The 15 months cumulative mortality among BF and NBF children was 3.5% and 6.4% (P = .03), respectively. CONCLUSIONS: Cessation of BF is associated with acute morbidity events and cumulative mortality. Prolonged BF should be encouraged, in addition to close monitoring of infant health and provision of support services.
BACKGROUND: We assessed morbidity rates during short intervals that accompanied weaning and cumulative mortality among HIV-exposed, uninfected infants enrolled in the postexposure prophylaxis of infants in Malawi (PEPI-Malawi) trial. METHODS:Women were counseled to stop breastfeeding (BF) by 6 months in the PEPI-Malawi trial. HIV-uninfectedinfants were included in this analysis starting at age 6 months. Breastfeeding and morbidity (illness and/or hospital admission and malnutrition [weight-for-age Z-score, ≤2]) were assessed during age intervals of 6-9, 9-12, and 12-15 months. BF was defined as any BF at the start and end of the interval and no breastfeeding (NBF) was defined as NBF at any time during the interval. The association of NBF with morbidity at each mutually exclusive interval was assessed using Poisson regression models controlling for other factors. Cumulative mortality among infants aged 6-15 months with BF and NBF was assessed using an extended Kaplan-Meier method. RESULTS: At age 6 months, 1761 HIV-uninfectedinfants were included in the study. The adjusted rate ratios for illnesses and/or hospital admission for NBF, compared with BF, was 1.7 (P < .0001) at 6-9 months, 1.66 (P = .0001) at 9-12 months, and 1.75 (P = .0008) at 12-15 months. The rates of morbidity were consistently higher among NBF infants during each age interval, compared with BF infants. The 15 months cumulative mortality among BF and NBF children was 3.5% and 6.4% (P = .03), respectively. CONCLUSIONS: Cessation of BF is associated with acute morbidity events and cumulative mortality. Prolonged BF should be encouraged, in addition to close monitoring of infant health and provision of support services.
Authors: Jonathan Mermin; John Lule; John Paul Ekwaru; Robert Downing; Peter Hughes; Rebecca Bunnell; Samuel Malamba; Ray Ransom; Frank Kaharuza; Alex Coutinho; Aminah Kigozi; Robert Quick Journal: AIDS Date: 2005-07-01 Impact factor: 4.177
Authors: Darlington M Mwenya; Bambos M Charalambous; Patrick P J Phillips; James C L Mwansa; Sarah L Batt; Andrew J Nunn; Sarah Walker; Diana M Gibb; Stephen H Gillespie Journal: Antimicrob Agents Chemother Date: 2010-06-28 Impact factor: 5.191
Authors: Ibou Thior; Shahin Lockman; Laura M Smeaton; Roger L Shapiro; Carolyn Wester; S Jody Heymann; Peter B Gilbert; Lisa Stevens; Trevor Peter; Soyeon Kim; Erik van Widenfelt; Claire Moffat; Patrick Ndase; Peter Arimi; Poloko Kebaabetswe; Patson Mazonde; Joseph Makhema; Kenneth McIntosh; Vladimir Novitsky; Tun-Hou Lee; Richard Marlink; Stephen Lagakos; Max Essex Journal: JAMA Date: 2006-08-16 Impact factor: 56.272
Authors: Charles S Chasela; Michael G Hudgens; Denise J Jamieson; Dumbani Kayira; Mina C Hosseinipour; Athena P Kourtis; Francis Martinson; Gerald Tegha; Rodney J Knight; Yusuf I Ahmed; Deborah D Kamwendo; Irving F Hoffman; Sascha R Ellington; Zebrone Kacheche; Alice Soko; Jeffrey B Wiener; Susan A Fiscus; Peter Kazembe; Innocent A Mofolo; Maggie Chigwenembe; Dorothy S Sichali; Charles M van der Horst Journal: N Engl J Med Date: 2010-06-17 Impact factor: 91.245
Authors: Stephen Arpadi; Ashraf Fawzy; Grace M Aldrovandi; Chipepo Kankasa; Moses Sinkala; Mwiya Mwiya; Donald M Thea; Louise Kuhn Journal: Am J Clin Nutr Date: 2009-06-24 Impact factor: 7.045
Authors: Denise J Jamieson; Charles S Chasela; Michael G Hudgens; Caroline C King; Athena P Kourtis; Dumbani Kayira; Mina C Hosseinipour; Deborah D Kamwendo; Sascha R Ellington; Jeffrey B Wiener; Susan A Fiscus; Gerald Tegha; Innocent A Mofolo; Dorothy S Sichali; Linda S Adair; Rodney J Knight; Francis Martinson; Zebrone Kacheche; Alice Soko; Irving Hoffman; Charles van der Horst Journal: Lancet Date: 2012-04-26 Impact factor: 79.321
Authors: Roger L Shapiro; Douglas Kitch; Anthony Ogwu; Michael D Hughes; Shahin Lockman; Kathleen Powis; Sajini Souda; Claire Moffat; Sikhulile Moyo; Kenneth McIntosh; Erik van Widenfelt; Sheryl Zwerski; Loeto Mazhani; Joseph Makhema; Max Essex Journal: AIDS Date: 2013-07-31 Impact factor: 4.177
Authors: Carina Marquez; Jaffer Okiring; Gabriel Chamie; Theodore D Ruel; Jane Achan; Abel Kakuru; Moses R Kamya; Edwin D Charlebois; Diane V Havlir; Grant Dorsey Journal: J Trop Pediatr Date: 2014-08-21 Impact factor: 1.165
Authors: Patricia M Flynn; Taha E Taha; Mae Cababasay; Mary Glenn Fowler; Lynne M Mofenson; Maxensia Owor; Susan Fiscus; Lynda Stranix-Chibanda; Anna Coutsoudis; Devasena Gnanashanmugam; Nahida Chakhtoura; Katie McCarthy; Cornelius Mukuzunga; Bonus Makanani; Dhayendre Moodley; Teacler Nematadzira; Bangini Kusakara; Sandesh Patil; Tichaona Vhembo; Raziya Bobat; Blandina T Mmbaga; Maysseb Masenya; Mandisa Nyati; Gerhard Theron; Helen Mulenga; Kevin Butler; David E Shapiro Journal: J Acquir Immune Defic Syndr Date: 2018-04-01 Impact factor: 3.731
Authors: Moses R Kamya; James Kapisi; Victor Bigira; Tamara D Clark; Stephen Kinara; Florence Mwangwa; Mary K Muhindo; Abel Kakuru; Francesca T Aweeka; Liusheng Huang; Prasanna Jagannathan; Jane Achan; Diane V Havlir; Philip J Rosenthal; Grant Dorsey Journal: AIDS Date: 2014-11-28 Impact factor: 4.177
Authors: Athena P Kourtis; Jeffrey Wiener; Dumbani Kayira; Charles Chasela; Sascha R Ellington; Lisa Hyde; Mina Hosseinipour; Charles van der Horst; Denise J Jamieson Journal: AIDS Date: 2013-03-13 Impact factor: 4.177
Authors: Louise Kuhn; Hae-Young Kim; Jan Walter; Donald M Thea; Moses Sinkala; Mwiya Mwiya; Chipepo Kankasa; Don Decker; Grace M Aldrovandi Journal: Sci Transl Med Date: 2013-04-17 Impact factor: 17.956
Authors: Athena P Kourtis; Chris C Ibegbu; Jeffrey Wiener; Caroline C King; Gerald Tegha; Deborah Kamwendo; Jacob Kumwenda; Surinder P Kaur; Valerie Flax; Sascha Ellington; Zebrone Kacheche; Dumbani Kayira; Charles Chasela; Charles van der Horst; Denise J Jamieson Journal: J Infect Dis Date: 2013-05-17 Impact factor: 5.226